| abstract |
Novel castor molecules having an activity of the castor type are described, as well as conjugates of targeted toxins containing them. The molecules are characterized by a modification within the lectin-binding regions of the B chain. Methods of making these molecules and conjugates are described, as well as the therapeutic compositions containing them. |